Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study [Phase 3]

View source ↗

Summary

A real-world Phase 3 trial evaluating fenofibrate in combination with ursodeoxycholic acid for primary biliary cholangitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)
  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Primary Biliary Cholangitis (PBC) | Phase 3 | Status: RECRUITING